The latest installment in the Lupin the Third franchise is throwing the world's greatest thief into his deadliest heist yet.

We are committed to innovation and advancing cutting-edge science to offer meaningful therapeutic options for patients with difficult-to-treat cancers," said Vinita Gupta, CEO, Lupin. Current data ...

Drug maker Lupin on Monday said it has entered into a licence and supply agreement with SteinCares for commercialisation of biosimilar ranibizumab across Latin America, excluding Mexico and Argentina.

This weekend will be a big one with not one, but two blockbusters opening in theaters, as well as several other films – there’s something for everyone. Mission: Impossible vs Lilo & Stitch ...

Lupin is now utilizing Honeywell’s Solstice Air in its respiratory inhalers, significantly improving respiratory care with propellants that have near-zero global warming potential. This ...

Drugmaker Lupin has entered into a licence and supply agreement with SteinCares for commercialisation of its biosimilar ranibizumab across Latin America, excluding Mexico and Argentina.

Lupin has launched eslicarbazepine acetate tablets, 200 mg, 400 mg, 600 mg and 800 mg. Lupin is one of the first ANDA applicants and is eligible for 180 days of shared generic exclusivity ...

Lupin has received the Food and Drug Administration’s green light for rivaroxaban tablets, in 10 mg, 15 mg and 20 mg, which is the generic of Janssen’s Xarelto. This product will be ...

The pharmaceutical company announced that it has signed a licensing and supply deal with SteinCares for its biosimilar Ranibizumab in Latin American markets, excluding Mexico and Argentina ...

Lupin Limited on Monday announced that it has entered into a licensing and supply pact with SteinCares. The agreement is for biosimilar Ranibizumab in Latin America, excluding Mexico and Argentina.